Inhibrx Biosciences Inc.
(INBX)
undefined
undefined%
At close: undefined
14.62
0.07%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -241.36M | -145.23M | -81.77M | -76.12M | -51.40M | -31.02M | -22.08M | -8.27M |
Depreciation & Amortization | 1.19M | 1.23M | 1.20M | 1.02M | 1.16M | 676.00K | 399.00K | 253.00K |
Stock-Based Compensation | 24.85M | 17.79M | 15.05M | 5.02M | 3.97M | 2.48M | 1.18M | 552.00K |
Other Working Capital | 13.76M | 3.74M | -1.67M | -5.61M | 8.94M | 556.00K | -556.00K | -6.35M |
Other Non-Cash Items | 6.67M | 5.09M | 2.73M | 11.56M | 9.61M | 522.00K | 746.00K | -3.37M |
Deferred Income Tax | - | - | -9.00K | -2.14M | 1.08M | - | - | - |
Change in Working Capital | 15.35M | 3.16M | -17.52M | 12.69M | 3.48M | 4.25M | 999.00K | -6.28M |
Operating Cash Flow | -193.31M | -115.30M | -80.32M | -47.97M | -32.08M | -23.09M | -18.75M | -18.11M |
Capital Expenditures | -4.59M | -686.00K | -864.00K | -1.36M | -1.81M | -1.43M | -1.34M | -215.00K |
Acquisitions | - | - | 55.00K | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - | - | - | - |
Other Investing Acitivies | - | - | 55.00K | - | - | - | - | - |
Investing Cash Flow | -4.59M | -686.00K | -809.00K | -1.36M | -1.81M | -1.43M | -1.34M | -215.00K |
Debt Repayment | - | - | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | -828.00K | -1.38M | - |
Other Financial Acitivies | 201.96M | 128.81M | 83.77M | 166.46M | 43.33M | 13.98M | 14.91M | 28.77M |
Financial Cash Flow | 201.96M | 258.55M | 83.77M | 166.46M | 43.33M | 13.15M | 13.54M | 28.77M |
Net Cash Flow | 4.06M | 142.56M | 2.64M | 117.12M | 9.44M | -11.37M | -6.55M | 10.45M |
Free Cash Flow | -197.90M | -115.99M | -81.19M | -49.33M | -33.89M | -24.52M | -20.09M | -18.32M |